Snapshot
The global Meningococcal Vaccines market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Meningococcal Vaccines by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Menactra
Menomune
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Meningococcal Vaccines Industry
Figure Meningococcal Vaccines Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Meningococcal Vaccines
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Meningococcal Vaccines
1.2.2 Downstream
Table Application Segment of Meningococcal Vaccines
Table Global Meningococcal Vaccines Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Meningococcal Vaccines Market by Type
3.1 By Type
3.1.1 Menactra
Table Major Company List of Menactra
3.1.2 Menomune
Table Major Company List of Menomune
3.2 Market Size
Table Global Meningococcal Vaccines Market 2016-2020, by Type, in USD Million
Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in USD Million
Table Global Meningococcal Vaccines Market 2016-2020, by Type, in Volume
Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in USD Million
Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.1.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.1.2 GlaxoSmithKline Products & Services
4.1.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 JN-International Medical (Company Profile, Sales Data etc.)
4.2.1 JN-International Medical Profile
Table JN-International Medical Overview List
4.2.2 JN-International Medical Products & Services
4.2.3 JN-International Medical Business Operation Conditions
Table Business Operation of JN-International Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis International (Company Profile, Sales Data etc.)
4.3.1 Novartis International Profile
Table Novartis International Overview List
4.3.2 Novartis International Products & Services
4.3.3 Novartis International Business Operation Conditions
Table Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi (Company Profile, Sales Data etc.)
4.4.1 Sanofi Profile
Table Sanofi Overview List
4.4.2 Sanofi Products & Services
4.4.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer (Company Profile, Sales Data etc.)
4.5.1 Pfizer Profile
Table Pfizer Overview List
4.5.2 Pfizer Products & Services
4.5.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Baxter International (Company Profile, Sales Data etc.)
4.6.1 Baxter International Profile
Table Baxter International Overview List
4.6.2 Baxter International Products & Services
4.6.3 Baxter International Business Operation Conditions
Table Business Operation of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Meningococcal Vaccines Sales Revenue 2016-2020, by Company, in USD Million
Table Global Meningococcal Vaccines Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Meningococcal Vaccines Sales Revenue Share in 2020, by Company, in USD Million
Table Global Meningococcal Vaccines Sales Volume 2016-2020, by Company, in Volume
Table Global Meningococcal Vaccines Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Meningococcal Vaccines Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Meningococcal Vaccines Market Concentration, in 2020
Figure Europe Meningococcal Vaccines Market Market Concentration, in 2020
Figure Asia-Pacific Meningococcal Vaccines MMarket Concentration, in 2020
Figure South America Meningococcal Vaccines Market Concentration, in 2020
Figure Middle East & Africa Meningococcal Vaccines Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Pneumonia
Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in Volume
6.1.2 Demand in Meningitis
Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in Volume
6.1.3 Demand in Bacteremia
Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in Volume
6.1.4 Demand in Others (Arthritis, Conjunctivitis, Urethritis)
Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in USD Million
Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in USD Million
Figure Meningococcal Vaccines Market Growth 2021-2026, by Application, in USD Million
Figure Meningococcal Vaccines Market Share in 2026, by Application, in USD Million
Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in Volume
Table Meningococcal Vaccines Market Growth 2021-2026, by Application, in Volume
Table Meningococcal Vaccines Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Meningococcal Vaccines Production 2016-2020, by Region, in USD Million
Table Meningococcal Vaccines Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Meningococcal Vaccines Market 2016-2020, by Region, in USD Million
Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in USD Million
Table Global Meningococcal Vaccines Market 2016-2020, by Region, in Volume
Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in USD Million
Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Meningococcal Vaccines
2. Table Application Segment of Meningococcal Vaccines
3. Table Global Meningococcal Vaccines Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Menomune
5. Table Global Meningococcal Vaccines Market 2016-2020, by Type, in USD Million
6. Table Global Meningococcal Vaccines Market 2016-2020, by Type, in Volume
7. Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Meningococcal Vaccines Market Forecast 2021-2026, by Type, in Volume
9. Table GlaxoSmithKline Overview List
10. Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table JN-International Medical Overview List
12. Table Business Operation of JN-International Medical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Novartis International Overview List
14. Table Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Sanofi Overview List
16. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Pfizer Overview List
18. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Baxter International Overview List
20. Table Business Operation of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Global Meningococcal Vaccines Sales Revenue 2016-2020, by Company, in USD Million
22. Table Global Meningococcal Vaccines Sales Revenue Share 2016-2020, by Company, in USD Million
23. Table Global Meningococcal Vaccines Sales Volume 2016-2020, by Company, in Volume
24. Table Global Meningococcal Vaccines Sales Volume Share 2016-2020, by Company, in Volume
25. Table Regional Demand Comparison List
26. Table Major Application in Different Regions
27. Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in USD Million
28. Table Meningococcal Vaccines Demand Forecast 2021-2026, by Application, in Volume
29. Table Meningococcal Vaccines Market Growth 2021-2026, by Application, in Volume
30. Table Meningococcal Vaccines Market Share in 2026, by Application, in Volume
31. Table Meningococcal Vaccines Production 2016-2020, by Region, in USD Million
32. Table Meningococcal Vaccines Production 2016-2020, by Region, in Volume
33. Table Global Meningococcal Vaccines Market 2016-2020, by Region, in USD Million
34. Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in USD Million
35. Table Global Meningococcal Vaccines Market 2016-2020, by Region, in Volume
36. Table Global Meningococcal Vaccines Market Share 2016-2020, by Region, in Volume
37. Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
38. Table North America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
39. Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
40. Table Europe Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
41. Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
42. Table Asia-Pacific Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
43. Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
44. Table South America Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
45. Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in USD Million
46. Table Middle East & Africa Meningococcal Vaccines Market Size 2016-2020, by Country, in Volume
47. Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in USD Million
48. Table Meningococcal Vaccines Market Forecast 2021-2026, by Region, in Volume
49. Table Price Factors List
List of Figure
1. Figure Meningococcal Vaccines Industry Chain Structure
2. Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Meningococcal Vaccines Market Growth 2016-2020, by Type, in Volume
4. Figure Global Meningococcal Vaccines Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Meningococcal Vaccines Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Meningococcal Vaccines Market Concentration, in 2020
7. Figure Europe Meningococcal Vaccines Market Market Concentration, in 2020
8. Figure Asia-Pacific Meningococcal Vaccines MMarket Concentration, in 2020
9. Figure South America Meningococcal Vaccines Market Concentration, in 2020
10. Figure Middle East & Africa Meningococcal Vaccines Market Concentration, in 2020
11. Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in USD Million
12. Figure Meningococcal Vaccines Demand in Pneumonia, 2016-2020, in Volume
13. Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in USD Million
14. Figure Meningococcal Vaccines Demand in Meningitis, 2016-2020, in Volume
15. Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in USD Million
16. Figure Meningococcal Vaccines Demand in Bacteremia, 2016-2020, in Volume
17. Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in USD Million
18. Figure Meningococcal Vaccines Demand in Others (Arthritis, Conjunctivitis, Urethritis), 2016-2020, in Volume
19. Figure Meningococcal Vaccines Market Growth 2021-2026, by Application, in USD Million
20. Figure Meningococcal Vaccines Market Share in 2026, by Application, in USD Million
21. Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
22. Figure North America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
23. Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
27. Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
28. Figure South America Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Meningococcal Vaccines Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview
The Hepatitis B Vaccines Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/...
The Vaccines Isothermal Boxes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Human Rabies Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...
The global Recombinant Vector Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players ...
The global DTaP and Tdap Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
The global Japanese Encephalitis Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...